Clinical implication of endothelial progenitor cells.
Carlo Foresta1, Luca De Toni, Alberto Ferlin
1University of Padova, Department of Histology, Microbiology and Medical Biotechnologies, Centre for Male Gamete Cryopreservation, Padova, Italy. carlo.foresta@unipd.it
Expert Review of Molecular Diagnostics
|December 25, 2009
Summary
Endothelial progenitor cells (EPCs) are crucial for blood vessel repair and growth. Their numbers predict cardiovascular disease risk, highlighting their therapeutic potential in vascular regenerative medicine.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Regenerative Medicine
Background:
- Endothelial progenitor cells (EPCs) are key for in vivo vessel growth and repair.
- While their origin is debated, EPCs differentiate into endothelial cells, contributing to neoangiogenesis.
- EPCs originate from bone marrow hematopoietic stem cells and circulate systemically.
Purpose of the Study:
- To define the role and therapeutic potential of EPCs in vascular health.
- To explore EPCs' link to cardiovascular risk factors and disease progression.
- To assess EPCs for applications in vascular regenerative medicine.
Main Methods:
- Review of current literature on EPC origin, function, and clinical relevance.
- Analysis of studies correlating EPC number/function with endothelial function and cardiovascular risk.
- Evaluation of evidence for EPCs in treating ischemic diseases.
Main Results:
- EPCs directly contribute to neovascularization and endothelial repair.
- Reduced EPC numbers are independent predictors of cardiovascular morbidity, mortality, and atherosclerosis.
- EPC number and function correlate positively with endothelial function and inversely with cardiovascular risk factors.
Conclusions:
- EPCs play a vital role in maintaining and repairing vascular endothelium.
- EPCs hold significant therapeutic promise for vascular regenerative medicine, particularly in ischemic conditions.
- Further research into EPCs could lead to novel cardiovascular disease treatments.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...